WHAT WE RESEARCH
AND FOR WHOM

EXAMPLES OF OUR WORK

 

We have a broad range of experience with our research projects involving a multitude of conditions and clients. These experiences have fine-tuned our open and neutral perception necessary for the design of an appropriate research strategy in your specific sector.

Please feel free to order some samples of our work

ETHNOGRAPHIC RHEUMATOID ARTHRITIS PATIENT STUDY

 

PHASE 1

IN-DEPTH-INTERVIEWS / RA-PATIENTS

OBJECTIVE: PATIENT EXPERIENCE AND EVALUATION BY PATIENTS
  • Familiarity with and usage of various treatments for RA pain management
  • Emotional components
  • Ideal products and review of the concepts
PHASE 2

VIDEO DIARY + IN-DEPTH-INTERVIEWS / RA-PATIENTS

OBJECTIVE:
  • Gaining insight into the everyday lives of patients suffering from rheumatoid arthritis in order to enable the development of suitable product positioning approaches and product messages

FACE TO FACE INTERVIEWS VIROLOGY

 

STATUS-QUO-ANALYSIS INFECTIOUS DISEASE / SPECIALISTS / VIROLOGISTS

IN-DEPTH-INTERVIEWS

OBJECTIVE:
  • By means of a study conducted amongst infectious disease specialists / virologists (specialist centres), XY Corporation wishes to assess both the current image of XY as well as customer satisfaction within that target group
  • Gathering suggestions for measures (e.g., services / communication channels) to foster even closer cooperation as well as for potential marketing activities
  • 40 face-to-face interviews conducted with infectious disease specialists / virologists

PAIN MEDICATION MULTIPHASE STUDY

LAUNCH-POSITIONING

 

PHASE 1

IN-DEPTH-INTERVIEWS
PAIN SPECIALISTS & PAIN PATIENTS

OBJECTIVE: PAIN SPECIALISTS
  • Perceptions of peripheral neuropathic pain and treatment goals
    Patient typology
  • Understanding the competitive landscape and unmet needs
  • Evaluation of the product profile of Product X and evaluation of the brand
  • Understanding how the brand Product X could potentially be further developed
OBJECTIVE: PATIENTS
  • Perceptions of peripheral neuropathic pain
  • Day-to-day life with peripheral neuropathic pain, thoughts on their medication
  • Relationships with doctors
  • Evaluation of Product X
PHASE 2

IN-DEPTH-INTERVIEWS + MINI GROUPS
PAIN SPECIALISTS

OBJECTIVE: MESSAGE FLOW AND POSITIONING
  • Perceptions of the therapy area
  • Product profile
  • Key messages
  • Product positioning
  • Narrative flow of the key messages
PHASE 3

IN-DEPTH-INTERVIEWS / GPs

OBJECTIVE: FINE TUNING OF MESSAGE
  • FLOW AND POSITIONING
  • Treatment goals
  • Brief introduction of the product profile
  • Gallery exercise – spontaneous reactions to, and recall of the concepts
  • In-depth review of each concept, one after the other
  • Identification of the best concept / best match with the communication goal

POST-LAUNCH

 

PHASE 4

IN-DEPTH-INTERVIEWS + MINI GROUPS / GPS

OBJECTIVE: INCREASING SALES POSTLAUNCH & IDENTIFYING POTENTIAL PROBLEM AREAS
  • Perceptions of peripheral neuropathic pain and treatment goals
  • Perceptions of pharmaceutical products currently used to treat peripheral neuropathic pain
  • Respondents’ past experiences with Product X
  • Measures to increase the market acceptance of Product X
PHASE 5

IN-DEPTH-INTERVIEWS + TRIADS / DYADS USERS & NON-USERS

OBJECTIVE: MESSAGE TESTING AND PATIENT PROFILE DEVELOPMENT
  • Current perceptions of available treatments
  • Evaluation of the messages
  • Exploration, evaluation and refinement of the patient profiles
  • Development of the narrative flow

 

 

 

 

 

 

 

 

EXAMPLES OF OUR WORK

 

We have a broad range of experience with our research projects involving a multitude of conditions and clients. These experiences have fine-tuned our open and neutral perception necessary for the design of an appropriate research strategy in your specific sector.

Please feel free to order some samples of our work

ETHNOGRAPHIC RHEUMATOID ARTHRITIS PATIENT STUDY

 

PHASE 1

IN-DEPTH-INTERVIEWS / RA-PATIENTS

OBJECTIVE: PATIENT EXPERIENCE AND EVALUATION BY PATIENTS
  • Familiarity with and usage of various treatments for RA pain management
  • Emotional components
  • Ideal products and review of the concepts
PHASE 2

VIDEO DIARY + IN-DEPTH-INTERVIEWS / RA-PATIENTS

OBJECTIVE:
  • Gaining insight into the everyday lives of patients suffering from rheumatoid arthritis in order to enable the development of suitable product positioning approaches and product messages

FACE TO FACE INTERVIEWS VIROLOGY

 

STATUS-QUO-ANALYSIS INFECTIOUS DISEASE / SPECIALISTS / VIROLOGISTS

IN-DEPTH-INTERVIEWS

OBJECTIVE:
  • By means of a study conducted amongst infectious disease specialists / virologists (specialist centres), XY Corporation wishes to assess both the current image of XY as well as customer satisfaction within that target group
  • Gathering suggestions for measures (e.g., services / communication channels) to foster even closer cooperation as well as for potential marketing activities
  • 40 face-to-face interviews conducted with infectious disease specialists / virologists

PAIN MEDICATION MULTIPHASE STUDY

LAUNCH-POSITIONING

 

PHASE 1

IN-DEPTH-INTERVIEWS
PAIN SPECIALISTS & PAIN PATIENTS

OBJECTIVE: PAIN SPECIALISTS
  • Perceptions of peripheral neuropathic pain and treatment goals
    Patient typology
  • Understanding the competitive landscape and unmet needs
  • Evaluation of the product profile of Product X and evaluation of the brand
  • Understanding how the brand Product X could potentially be further developed
OBJECTIVE: PATIENTS
  • Perceptions of peripheral neuropathic pain
  • Day-to-day life with peripheral neuropathic pain, thoughts on their medication
  • Relationships with doctors
  • Evaluation of Product X
PHASE 2

IN-DEPTH-INTERVIEWS + MINI GROUPS
PAIN SPECIALISTS

OBJECTIVE: MESSAGE FLOW AND POSITIONING
    • Perceptions of the therapy area
    • Product profile
    • Key messages
    • Product positioning
    • Narrative flow of the key messages
PHASE 3

IN-DEPTH-INTERVIEWS / GPs

OBJECTIVE: FINE TUNING OF MESSAGE
      • FLOW AND POSITIONING
      • Treatment goals
      • Brief introduction of the product profile
      • Gallery exercise – spontaneous reactions to, and recall of the concepts
      • In-depth review of each concept, one after the other
      • Identification of the best concept / best match with the communication goal

POST-LAUNCH

 

PHASE 4

IN-DEPTH-INTERVIEWS + MINI GROUPS / GPS

OBJECTIVE: INCREASING SALES POSTLAUNCH & IDENTIFYING POTENTIAL PROBLEM AREAS
      • Perceptions of peripheral neuropathic pain and treatment goals
      • Perceptions of pharmaceutical products currently used to treat peripheral neuropathic pain
      • Respondents’ past experiences with Product X
      • Measures to increase the market acceptance of Product X
PHASE 5

IN-DEPTH-INTERVIEWS + TRIADS / DYADS USERS & NON-USERS

OBJECTIVE: MESSAGE TESTING AND PATIENT PROFILE DEVELOPMENT
        • Current perceptions of available treatments
        • Evaluation of the messages
        • Exploration, evaluation and refinement of the patient profiles
        • Development of the narrative flow

 

 

+1
Happy Clients
+1
Years of team expierence
+1
Contacts to HPCs
+1
Happy Clients
+1
Years of team expierence
+1
Contacts to HPCs

OUR EXPERTISE

 

We have worked across a wide range of therapy areas and sectors, i.e.:

Breast
Bladder
Colorectal
NSCLC/SCLC
Ovarian
Prostate
Pancreatic
Thyroid cancer
Uterus Myoma
Renal

Carbapenem-resistant gram-negative infections
Hepatitis
HIV
Influenza

Ankylosing Spondylitis
Osteoarthritis
Paget ́s Disease
Rheumatoid Arthritis
Systemic lupus erythematosus

ALL
AML
CLL
Lymphoma – FL/NHL
Multiple myeloma
Myelofibrosis
Paroxysmal nocturnal hemoglobinuria (PNH)
Squamous cell carcinoma

Acne
Eczema
Psoriasis
Malignant Melanomas
Systemic Sclerosis

Attention deficit disorder
Alzheimer
Bipolar disorders
Chronic Pain Management
Drug Substitution
Depression
Epilepsy
Fibromyalgia
Migraine
Multiple sclerosis
Parkinsons ́disease
Restless Leg Syndrome
Schizoaffective Disorder
Schizophrenia
Spinal muscular atrophy (SMA)

Erectile Dysfunction
Intermit catheters
Hyperactive bladder
Urinary Incontinence

Atypical hemolytic uremic
syndrome (aHUS)
Cystic fibrosis
CHD
Fabry disease
Gaucher disease
Hereditary angioedema (HAE)
Haemophilia
Myasthenia gravis
Pulmonary arterial hypertension (PAH)
Primary immune deficiency diseases (PIDDs)

Age-Related Macular Degeneration (AMD)
Macular holes
Uveitis
Vitreomacular adhesion (VMA)

Breast
Bladder
Colorectal
NSCLC/SCLC
Ovarian
Prostate
Pancreatic
Thyroid cancer
Uterus Myoma
Renal

Carbapenem-resistant gram-negative infections
Hepatitis
HIV
Influenza

Ankylosing Spondylitis
Osteoarthritis
Paget ́s Disease
Rheumatoid Arthritis
Systemic lupus erythematosus

Attention deficit disorder
Alzheimer
Bipolar disorders
Chronic Pain Management
Drug Substitution
Depression
Epilepsy
Fibromyalgia
Migraine
Multiple sclerosis
Parkinsons ́disease
Restless Leg Syndrome
Schizoaffective Disorder
Schizophrenia
Spinal muscular atrophy (SMA)

Erectile Dysfunction
Intermit catheters
Hyperactive bladder
Urinary Incontinence

ALL
AML
CLL
Lymphoma – FL/NHL
Multiple myeloma
Myelofibrosis
Paroxysmal nocturnal hemoglobinuria (PNH)
Squamous cell carcinoma

Acne
Eczema
Psoriasis
Malignant Melanomas
Systemic Sclerosis

Atypical hemolytic uremic
syndrome (aHUS)
Cystic fibrosis
CHD
Fabry disease
Gaucher disease
Hereditary angioedema (HAE)
Haemophilia
Myasthenia gravis
Pulmonary arterial hypertension (PAH)
Primary immune deficiency diseases (PIDDs)

Age-Related Macular Degeneration (AMD)
Macular holes
Uveitis
Vitreomacular adhesion (VMA)

HAEMATOLOGY & ONCOLOGY

 

We have years of experience and expertise in oncology and heamatoncology.

Our expertise spans the entire lifecycle of oncology drugs from early development to commercialisation.

Using our in-depth knowledge of the oncology landscape helps you to develop a distinct brand and to create powerful marketing material.

PRE-LAUNCH STUDY CAR-T

 

12 IDIs 60 MIN / HEMATOLOGIST & TRANSPLANTERS

IN-DEPTH-INTERVIEWS
OBJECTIVE: IDENTIFYING THE CAR-T STAKEHOLDERS

 

        • Identification of overall awareness of CAR-T therapy across physicians (hematologist & transplanters).
        • Identification of different HCP segments for using CAR-T
        • Who is open to use CAR-T and what are the drivers/barriers
        • Patient typology -What patients will be referred vs. not referred for CAR-T therapy?
        • What patients are most appropriate for CAR-T therapy?
        • Understanding the competitive landscape
        • How choose HCPs one CAR-T over another?
        • Evaluation of the product profile of Product X

 

HAEMATOLOGY & ONCOLOGY

 

We have years of experience and expertise in oncology and heamatoncology.

Our expertise spans the entire lifecycle of oncology drugs from early development to commercialisation.

Using our in-depth knowledge of the oncology landscape helps you to develop a distinct brand and to create powerful marketing material.

PRE-LAUNCH STUDY CAR-T

 

12 IDIs 60 MIN / HEMATOLOGIST & TRANSPLANTERS

IN-DEPTH-INTERVIEWS
OBJECTIVE: IDENTIFYING THE CAR-T STAKEHOLDERS

 

        • Identification of overall awareness of CAR-T therapy across physicians (hematologist & transplanters).
        • Identification of different HCP segments for using CAR-T
        • Who is open to use CAR-T and what are the drivers/barriers
        • Patient typology -What patients will be referred vs. not referred for CAR-T therapy?
        • What patients are most appropriate for CAR-T therapy?
        • Understanding the competitive landscape
        • How choose HCPs one CAR-T over another?
        • Evaluation of the product profile of Product X